Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 2/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.32 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31601775 | 0.92 | HDAC3 (0.31) | HDAC1HDAC3HDAC2HDAC10NCOR2 | |
| SCHEMBL31601723 | 0.85 | WNT3A (0.36) | LMNAMAPT | |
| SCHEMBL31601945 | 0.84 | CDC25A (0.35) | HDAC1HDAC3HDAC2HDAC10NCOR2 | |
| SCHEMBL31601866 | 0.81 | NR1D1 (0.33) | LMNA | |
| SCHEMBL31601925 | 0.76 | NPC1 (0.34) | LMNA | |
| SCHEMBL31601924 | 0.75 | NR1D1 (0.34) | — | |
| SCHEMBL31601913 | 0.73 | HDAC2 (0.35) | HDAC1HDAC3HDAC2HDAC10NCOR2 | |
| SCHEMBL31601900 | 0.73 | AKT1 (0.35) | LMNAMAPT | |
| SCHEMBL31601989 | 0.73 | ALDH1A1 (0.32) | — | |
| SCHEMBL31601881 | 0.73 | MEN1 (0.33) | HDAC1HDAC3HDAC2HDAC10NCOR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110815-A1 | IMIDAZO [1,2-B] PYRIDAZINE-BASED NOVEL COMPOUND AS CDK INHIBITOR AND USE THEREOF | 아이리드비엠에스 주식회사 | 2025-05-30 | — | — | WO | disclosed |